|
US20080261289A1
(en)
*
|
1996-12-13 |
2008-10-23 |
Schering-Plough Corporation |
Compositions comprising viruses and methods for concentrating virus preparations
|
|
US6544769B1
(en)
*
|
1996-12-13 |
2003-04-08 |
Schering Corporation |
Compostions comprising viruses and methods for concentrating virus preparations
|
|
US6759050B1
(en)
|
1998-12-03 |
2004-07-06 |
Avigen, Inc. |
Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
|
|
ES2185417T3
(es)
*
|
1998-12-03 |
2003-04-16 |
Avigen Inc |
Excipientes para usar en formulaciones farmaceuticas de virus adeno-asociados, y formulaciones farmaceuticas producidas con ellos.
|
|
US6225289B1
(en)
*
|
1998-12-10 |
2001-05-01 |
Genvec, Inc. |
Methods and compositions for preserving adenoviral vectors
|
|
FR2791999B1
(fr)
*
|
1999-04-09 |
2001-09-07 |
Aventis Pharma Sa |
Composition destinee a la conservation d'adenovirus recombinants infectieux
|
|
CZ20013560A3
(cs)
|
1999-04-09 |
2002-01-16 |
Aventis Pharma S. A. |
Tekutý nebo zmrazený přípravek určený k uchování rekombinantních infekčních adenovirů
|
|
US7456009B2
(en)
|
2000-03-07 |
2008-11-25 |
Merck & Co., Inc. |
Adenovirus formulations
|
|
JP5118798B2
(ja)
*
|
2000-03-07 |
2013-01-16 |
メルク・シャープ・エンド・ドーム・コーポレイション |
アデノウイルス製剤
|
|
EP1284287A4
(en)
*
|
2000-05-10 |
2004-10-13 |
Mitsubishi Pharma Corp |
METHOD FOR PRODUCING A VIRUS VECTOR
|
|
WO2003049763A1
(en)
|
2001-12-12 |
2003-06-19 |
Fh Faulding & Co Limited |
Composition for the preservation of viruses
|
|
JP2005515245A
(ja)
*
|
2002-01-18 |
2005-05-26 |
シエーリング アクチエンゲゼルシャフト |
アデノウィルスの安定化された配合物
|
|
KR100507794B1
(ko)
*
|
2003-02-11 |
2005-08-17 |
한미약품 주식회사 |
고농도 레트로 바이러스 현탁액 제조 방법
|
|
US20070148765A1
(en)
*
|
2003-11-19 |
2007-06-28 |
Evans Robert K |
Preservative-containing virus formulations
|
|
DK1780269T3
(da)
*
|
2004-02-23 |
2009-10-12 |
Crucell Holland Bv |
Virusrensningsmetoder
|
|
GB0502661D0
(en)
*
|
2005-02-09 |
2005-03-16 |
Stabilitech Ltd |
A desiccated product
|
|
CA2602944C
(en)
*
|
2005-04-11 |
2015-08-11 |
Crucell Holland B.V. |
Virus purification using ultrafiltration
|
|
CN1961961B
(zh)
*
|
2005-11-11 |
2010-05-26 |
深圳市源兴生物医药科技有限公司 |
一种药物制剂及其制备方法
|
|
EP2350268B1
(en)
|
2008-11-03 |
2014-12-24 |
Crucell Holland B.V. |
Method for the production of adenoviral vectors
|
|
NZ601424A
(en)
|
2010-02-15 |
2014-07-25 |
Crucell Holland Bv |
Method for the production of ad26 adenoviral vectors
|
|
US8771709B2
(en)
|
2010-09-20 |
2014-07-08 |
Crucell Holland B.V. |
Therapeutic vaccination against active Tuberculosis
|
|
WO2012041669A1
(en)
|
2010-09-27 |
2012-04-05 |
Crucell Holland B.V. |
Heterologous prime boost vaccination regimen against malaria
|
|
KR102023207B1
(ko)
|
2010-12-02 |
2019-11-25 |
온콜리틱스 바이오테크 인코포레이티드 |
동결건조 바이러스 제형
|
|
TW201233802A
(en)
|
2010-12-02 |
2012-08-16 |
Oncolytics Biotech Inc |
Liquid viral formulations
|
|
KR102044051B1
(ko)
|
2012-03-12 |
2019-11-12 |
얀센 백신스 앤드 프리벤션 비.브이. |
터미널 말단이 변경된 재조합 아데노바이러스의 배치
|
|
US8932607B2
(en)
|
2012-03-12 |
2015-01-13 |
Crucell Holland B.V. |
Batches of recombinant adenovirus with altered terminal ends
|
|
NZ630753A
(en)
|
2012-03-22 |
2016-12-23 |
Janssen Vaccines & Prevention Bv |
Vaccine against rsv
|
|
US9125870B2
(en)
|
2012-03-22 |
2015-09-08 |
Crucell Holland B.V. |
Vaccine against RSV
|
|
WO2014009433A1
(en)
|
2012-07-10 |
2014-01-16 |
Transgene Sa |
Mycobacterium resuscitation promoting factor for use as adjuvant
|
|
EP2872172B1
(en)
|
2012-07-10 |
2018-11-14 |
Transgene SA |
Mycobacterial antigen vaccine
|
|
TR201902513T4
(tr)
|
2013-04-25 |
2019-03-21 |
Janssen Vaccines & Prevention Bv |
Stabilize edilmiş çözünebilir prefüzyon RSV F polipeptitleri.
|
|
EP3010931B1
(en)
|
2013-06-17 |
2018-06-13 |
Janssen Vaccines & Prevention B.V. |
Stabilized soluble pre-fusion rsv f polypeptides
|
|
MX2016009072A
(es)
|
2014-01-09 |
2017-05-08 |
Transgene Sa |
Fusion de antigenos micobacterianos heterooligomericos.
|
|
US9721484B2
(en)
|
2014-06-23 |
2017-08-01 |
Humanetics Innovative Solutions, Inc. |
Shoulder kit assembly for crash test dummy
|
|
WO2016008976A1
(en)
|
2014-07-16 |
2016-01-21 |
Transgene Sa |
Oncolytic virus for expression of immune checkpoint modulators
|
|
US10008130B2
(en)
|
2014-09-17 |
2018-06-26 |
Humanetics Innovative Solutions, Inc. |
Omni-directional shoulder assembly for crash test dummy
|
|
WO2016128542A1
(en)
|
2015-02-13 |
2016-08-18 |
Transgene Sa |
Immunotherapeutic vaccine and antibody combination therapy
|
|
WO2016131945A1
(en)
|
2015-02-20 |
2016-08-25 |
Transgene Sa |
Combination product with autophagy modulator
|
|
WO2016166088A1
(en)
|
2015-04-14 |
2016-10-20 |
Janssen Vaccines & Prevention B.V. |
Recombinant adenovirus expressing two transgenes with a bidirectional promoter
|
|
CA2991540A1
(en)
|
2015-07-07 |
2017-01-12 |
Janssen Vaccines & Prevention B.V. |
Stabilized soluble pre-fusion respiratory syncytial sirus polypeptides
|
|
ES2839880T3
(es)
|
2015-07-07 |
2021-07-06 |
Janssen Vaccines & Prevention Bv |
Vacuna contra el VRS
|
|
EP3439694A1
(en)
|
2016-04-05 |
2019-02-13 |
Janssen Vaccines & Prevention B.V. |
Vaccine against rsv
|
|
PT3439672T
(pt)
|
2016-04-05 |
2021-02-24 |
Janssen Vaccines & Prevention Bv |
Proteína f do rsv pré-fusão solúvel e estabilizada para uso na profilaxia de infeção por rsv
|
|
JP7046835B2
(ja)
|
2016-05-12 |
2022-04-04 |
ヤンセン ファッシンズ アンド プリベンション ベーフェー |
強力でバランスのとれた双方向性プロモーター
|
|
KR102421049B1
(ko)
|
2016-05-30 |
2022-07-15 |
얀센 백신스 앤드 프리벤션 비.브이. |
안정화된 융합-전 rsv f 단백질
|
|
US11001858B2
(en)
|
2016-06-20 |
2021-05-11 |
Janssen Vaccines & Prevention B.V. |
Potent and balanced bidirectional promoter
|
|
US10744196B2
(en)
|
2016-07-14 |
2020-08-18 |
Janssen Vaccines & Prevention B.V. |
HPV vaccines
|
|
TW201825674A
(zh)
|
2016-09-09 |
2018-07-16 |
美商艾斯合顧問有限公司 |
表現雙特異性接合分子的溶瘤病毒
|
|
WO2018091680A1
(en)
|
2016-11-18 |
2018-05-24 |
Transgene Sa |
Cowpox-based oncolytic vectors
|
|
EP3562946B1
(en)
|
2016-12-28 |
2021-11-24 |
Transgene SA |
Oncolytic viruses and therapeutic molecules
|
|
KR102111244B1
(ko)
|
2017-02-09 |
2020-05-15 |
얀센 백신스 앤드 프리벤션 비.브이. |
이종 유전자의 발현을 위한 강력한 짧은 프로모터
|
|
US11229692B2
(en)
|
2017-05-17 |
2022-01-25 |
Janssen Vaccines & Prevention B.V. |
Methods and compositions for inducing protective immunity against RSV infection
|
|
WO2018210871A1
(en)
|
2017-05-17 |
2018-11-22 |
Janssen Vaccines & Prevention B.V. |
Methods and compositions for inducing protective immunity against rsv infection
|
|
WO2019020543A1
(en)
|
2017-07-28 |
2019-01-31 |
Transgene Sa |
ONCOLYTIC VIRUSES EXPRESSING AGENTS TARGETING METABOLIC IMMUNE MODULATORS
|
|
KR20200053518A
(ko)
|
2017-09-15 |
2020-05-18 |
얀센 백신스 앤드 프리벤션 비.브이. |
Rsv에 대한 면역의 안전한 유도를 위한 방법
|
|
WO2020011754A1
(en)
|
2018-07-09 |
2020-01-16 |
Transgene |
Chimeric vaccinia viruses
|
|
EP3875119A4
(en)
|
2018-10-30 |
2022-08-31 |
The University of Tokyo |
ONCOLYTIC VIRUS FOR CANCER THERAPY
|
|
SG11202104522UA
(en)
|
2018-11-13 |
2021-05-28 |
Janssen Vaccines & Prevention Bv |
Stabilized pre-fusion rsv f proteins
|
|
EP4097122A4
(en)
|
2020-01-31 |
2024-07-17 |
Beth Israel Deaconess Medical Center, Inc. |
COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING CORONAVIRUS INFECTION - SARS-COV-2 VACCINES
|
|
MA71423A
(fr)
|
2020-03-19 |
2025-04-30 |
Trizell Ltd. |
Système de stockage de virus sensible à la température
|
|
WO2022013221A1
(en)
|
2020-07-13 |
2022-01-20 |
Transgene |
Treatment of immune depression
|
|
KR20230152035A
(ko)
|
2021-02-01 |
2023-11-02 |
에쓰티 피에이치아이 테라퓨틱스 컴퍼니 리미티드 |
표적 단백질 분해 시스템 및 이의 응용
|
|
EP4294436A1
(en)
|
2021-02-19 |
2023-12-27 |
Janssen Vaccines & Prevention B.V. |
Stabilized pre-fusion rsv fb fantigens
|
|
WO2023020939A1
(en)
|
2021-08-17 |
2023-02-23 |
Janssen Pharmaceuticals, Inc. |
Sars-cov-2 vaccines
|
|
WO2023025899A2
(en)
|
2021-08-26 |
2023-03-02 |
Transgene |
Delivery system for targeting genes of the interferon pathway
|
|
WO2023111725A1
(en)
|
2021-12-14 |
2023-06-22 |
Janssen Pharmaceuticals, Inc. |
Sars-cov-2 vaccines
|
|
WO2023213763A1
(en)
|
2022-05-02 |
2023-11-09 |
Transgene |
Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
|
|
WO2023213764A1
(en)
|
2022-05-02 |
2023-11-09 |
Transgene |
Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf
|
|
JP2025523573A
(ja)
|
2022-07-01 |
2025-07-23 |
トランジェーヌ |
サーファクタントタンパク質－ｄとｔｎｆｓｆのメンバーを含んでなる融合タンパク質
|
|
AU2023326730A1
(en)
|
2022-08-18 |
2025-03-13 |
Transgene |
Chimeric poxviruses
|